Internal Reference Number: FOI_8557
Date Request Received: 04/04/2025 00:00:00
Date Request Replied To: 30/04/2025 00:00:00
This response was sent via: By Email
Request Summary: Atopic Dermatitis
Request Category: Researcher
| Question Number 1: How many patients were treated in the last 4 months (December 2024 to March 2025) by the dermatology department with each of the following products: • Abrocitinib • Acitretin • Alitretinoin • Azathioprine • Baricitinib • Ciclosporin • Dupilumab • Lebrikizumab • Methotrexate • Mycophenolate mofetil • Pimecrolimus • Phototherapy (UVB or PUVA) - for Atopic Dermatitis only • Tacrolimus ointment • Tralokinumab • Upadacitinib • Nemolizumab | |
| Answer To Question 1: • Abrocitinib <5 • Acitretin 32 • Alitretinoin <5 • Azathioprine <5 • Baricitinib 0 • Ciclosporin 11 • Dupilumab 29 • Lebrikizumab <5 • Methotrexate 36 • Mycophenolate mofetil <5 • Pimecrolimus 23 • Phototherapy (UVB or PUVA) - for Atopic Dermatitis only 12 • Tacrolimus ointment 50 • Tralokinumab <5 • Upadacitinib <5 • Nemolizumab 0 | |
| Question Number 2: . Of the patients treated in the last 4 months with any of the products listed in question 1, please provide the number of patients by the following age group: • 6 months to 5 • Age 6-11 • Age 12-17 • Age 18 and above | |
| Answer To Question 2: Phototherapy (UVB or PUVA) - for Atopic Dermatitis only: • 6 months to 5 - 0 • Age 6-11 - 0 • Age 12-17 - <5 • Age 18 and above - 11 We have made the assumption that the only medications being used in patients under 18 years of age are the topical products tacrolimus and pimecrolimus: Age 6 months to 5 years - <5 Age 6-11 - <5 Age 12-17 - <5 Age 18 and above - 68 All other medications would have been for patients age 18 and above. | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
